BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33274410)

  • 21. High seroprevalence of SARS-CoV-2 antibodies in healthcare workers in COVID-19 wards indicates an occupational hazard-a prospective cohort study during the first year of the COVID-19 pandemic in Kalmar County, Sweden.
    Hultqvist V; Bonnedahl J; Edwardsson J; Tjernberg I; Rydén I
    APMIS; 2023 Sep; 131(9):491-497. PubMed ID: 37462243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 Seroprevalence among the Health Care Staff of an Ophthalmological Reference Centre, a Cross Sectional Study.
    Magaña-Guerrero FS; Trujillo DH; Buentello-Volante B; Aguayo-Flores JE; Melgoza-González EA; Hernández J; Jiménez-Martínez MC; Pérez-Tapia SM; Garfias Y
    Ophthalmic Epidemiol; 2022 Oct; 29(5):483-490. PubMed ID: 34530684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of Healthcare Professionals in Contact with Patients Diagnosed with COVID-19 Detected Outside of the Pandemic Service in our Hospital].
    Korkmaz D; Konya P; Tünay H; Demirtürk N
    Mikrobiyol Bul; 2021 Apr; 55(2):194-206. PubMed ID: 33882651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the prevalence of anti-SARS-CoV-2 antibodies in groups of medical and non-medical professions.
    Biernacka P; Piekarska A; Berkan-Kawińska A
    Int J Occup Med Environ Health; 2023 Nov; 36(5):643-655. PubMed ID: 37768026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 antibody seroprevalence after the first wave among workers at a community healthcare system in the Greater Boston area.
    Bruno-Murtha LA; Osgood R; Lan FY; Buley J; Nathan N; Weiss M; MacDonald M; Kales SN; Sayah AJ
    Pathog Glob Health; 2021 Jul; 115(5):331-334. PubMed ID: 33729103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of SARS-CoV-2 in healthcare workers from outpatient facilities and retirement or nursing homes in a Swiss canton.
    Zürcher K; Mugglin C; Suter-Riniker F; Keller PM; Egger M; Müller S; Fluri M; Hoffmann M; Fenner L
    Swiss Med Wkly; 2021 Aug; 151():w30021. PubMed ID: 34495604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 in Mexican Health Care Workers after Two Years of the Pandemic: The Picture of an Ophthalmic Medical Centre.
    Garfias Y; Magaña-Guerrero FS; Buentello-Volante B; Cruz Vega IB; Castro Salas I; Sánchez Cisneros PJ; Aguayo Flores JE; Salas Lais AG; Muñoz Medina JE; Mata-Haro V; Reséndiz-Sandoval M; Vázquez-García VA; Hernández J
    Ophthalmic Epidemiol; 2023 Aug; 30(4):400-406. PubMed ID: 36184872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 seroprevalence in healthcare workers and risk factors.
    Weber S; Didelot A; Agrinier N; Peyrin-Biroulet L; Schvoerer E; Rabaud C; Jeulin H
    Infect Dis Health; 2022 Nov; 27(4):203-210. PubMed ID: 35644801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
    Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
    Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors.
    Kantele A; Lääveri T; Kareinen L; Pakkanen SH; Blomgren K; Mero S; Patjas A; Virtanen J; Uusitalo R; Lappalainen M; Järvinen A; Kurkela S; Jääskeläinen AJ; Vapalahti O; Sironen T
    Travel Med Infect Dis; 2021; 39():101949. PubMed ID: 33321195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of seropositivity for SARS-CoV-2 in hospital staff in the second wave of the pandemic in Slovenia.
    Socan M; Prosenc K; Kukec A; Zaletel-Kragelj L; Remec T; Grmek-Kosnik I
    Int J Occup Med Environ Health; 2022 Oct; 35(5):571-584. PubMed ID: 35856815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
    Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
    PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.
    Goldblatt D; Johnson M; Falup-Pecurariu O; Ivaskeviciene I; Spoulou V; Tamm E; Wagner M; Zar HJ; Bleotu L; Ivaskevicius R; Papadatou I; Jõgi P; Lischka J; Franckling-Smith Z; Isarova D; Grandjean L; Zavadska D
    J Hosp Infect; 2021 Apr; 110():60-66. PubMed ID: 33422589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation.
    Pandey HC; Dhiman Y; C S C; Coshic P; Jain P
    Transfus Apher Sci; 2021 Jun; 60(3):103118. PubMed ID: 33752991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2 antibodies, associated epidemiological factors and antibody kinetics among healthcare workers in Connecticut.
    Papasavas P; Olugbile S; Wu U; Robinson K; Roberts AL; O'Sullivan DM; McLaughlin T; Mather JF; Steinberg AC; Orlando R; Kumar A
    J Hosp Infect; 2021 Aug; 114():117-125. PubMed ID: 33930487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.